Vibrio furnissii

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Vibrio furnissii is a Gram-negative, non-spore-forming, facultatively anaerobic, motile, rod-shaped - curved bacterium. It has been detected in at least 3 gut microbiome compilation studies or metastudies. The DNA G+C content is 50.4%. Vibrio furnissii is probably a rare gut coloniser. (Brayton1986; Brenner1983; Farmer2005gBergey)



  • This organism has been recovered from human faeces and aquatic environments. The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread (notes: zoonotic pathogen). It is an opportunistic pathogen. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Brayton1986); (Brenner1983); (Farmer2005gBergey);
    Character Response
  • Substrates hydrolysed or digested:
  • chitin; DNA; gelatin;
  • ±
  • Strain-dependent hydrolysis or digestion:
  • starch; tyrosine;
  • 🧂
  • Salt tolerance:
  • tolerates 1% salt; tolerates 3-5% salt; strain-variable at 8(d)%;
  • 🌡
  • Temperature tolerance:
  • grows at 30℃; grows at 40℃;
  • H+
  • Acid from carbohydrates usually produced:
  • arabinose; L-arabinose; galactose; glucose; maltose; sucrose; trehalose; D-arabitol; mannitol;
  • ±
  • Strain-dependent acid from carbs:
  • mannose; rhamnose;
  • ⥅
  • Substrates assimilated or utilised:
  • L-arabinose; ethanol; galactose; gluconate; mannitol; sucrose; trehalose; alanine; D-alanine; γ-aminobutyrate; glutamate; proline; serine; tyrosine; citrate; heptanoate; DL-lactate; malate; L-malate; propionate; pyruvate; glutamine;
  • ±
  • Strain-dependent substrate utilisation:
  • cellubiose; mannose; δ-aminovalerate; histidine; acetate; 4-hydroxybenzoate;
  • Active enzymes:
  • alkaline phosphatase; acid phosphatase; arginine dihydrolase; DNase; esterase lipase C8; β-galactosidase; Leu arylamidase; lipase; oxidase;
    • SPECIAL FEATURES (Brayton1986); (Brenner1983); (Farmer2005gBergey);
    Character Response
  • ✗
  • Metabolites not produced:
  • H₂S; indole;
  • ✓
  • Methyl red test:
  • active
  • ✗
  • VP test:
  • not active
  • ±
  • ONPG test:
  • active for a few strains
  • KCN growth:
  • growth observed
  • ✓
  • Nitrate:
  • reduced
  • ✓
  • NO3➔NO2:
  • reduced
    • RESPONSE TO ANTIBIOTICS (Brayton1986); (Brenner1983); (Farmer2005gBergey);
    Class Active Resistant
  • Penicillins:
  • carbenicillin;
  • ampicillin; penicillin; penicillin G;
  • Cephalosporins:
  • cephalothin;
  • Tetracyclines:
  • tetracycline;
  • Quinolines:
  • nalidixic-acid;
  • Aminoglycosides:
  • gentamicin; kanamycin; streptomycin;
  • Heterocycles:
  • chloramphenicol; sulfadiazine;
  • Miscellaneous antibiotics:
  • colistin;

  • Brenner, D. J., Hickman-Brenner, F. W., Lee, J. V., Steigerwalt, A. G., Fanning, G. R., Hollis, D. G., Farmer, J. J., 3rd, Weaver, R. E., Joseph, S. W., & Seidler, R. J. (1983). Vibrio furnissii (formerly aerogenic biogroup of Vibrio fluvialis), a new species isolated from human feces and the environment. Journal of Clinical Microbiology, 18(4), 816–824.

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Gammaproteobacteria Order:  Vibrionales Family:  Vibrionaceae Genus:  Vibrio Gram stain:  neg O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Swimming Morphology:  Rod - curved
    Health:  Unknown
    Source:  human faeces and aquatic environments
    DNA G+C(%):  50.4
    Lower T(℃):  30(+)
    Mid T(℃):  40(+)
    NaCl 0.5-2%:  1(+)
    NaCl 3-5%:  3-5(+)
    NaCl >6%:  8(d)
    		Aesculin:  neg Urea:  neg Gelatin:  + Starch:  d Alginate:  neg Chitin:  + DNA:  + Tyrosine:  d Hippurate:  neg
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  + L-Arabinose:  + Galactose:  + Glucose:  + Mannose:  d Rhamnose:  d Xylose:  neg Cellubiose:  neg Lactose:  neg Maltose:  + Melibiose:  neg Sucrose:  + Trehalose:  + Amygdalin:  neg Adonitol:  neg D-Arabitol:  + L-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  w Inositol:  neg Mannitol:  + Sorbitol:  neg 5-Ketogluconate:  neg Me-α-D-Glc:  neg Salicin:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  + Galactose:  + Mannose:  d Rhamnose:  neg Xylose:  neg Cellubiose:  d Lactose:  neg Melibiose:  neg Sucrose:  + Trehalose:  + Ethanol:  + Gluconate:  + Mannitol:  + Salicin:  neg Sorbitol:  neg Ala:  + D-Ala:  + β-Ala:  neg 4-Aminobutyrate:  + 5-Aminovalerate:  d Betaine:  neg Glu:  + His:  d Leu:  neg Pro:  + Sarcosine:  neg Ser:  + Tyr:  + Acetate:  d Benzoate:  neg Citrate:  + Heptanoate:  + 4-Hydroxybenzoate:  d DL-Lactate:  + Malate:  + L-Malate:  + Malonate:  neg Mucate:  neg Propionate:  + Pyruvate:  + D-Tartrate:  neg L-Tartrate:  neg Valerate:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Urease:  neg α-Fucosidase:  neg α-Galactosidase:  neg β-Galactosidase:  + α-Glucosidase:  neg β-Glucuronidase:  neg α-Mannosidase:  neg ArgDH:  + LysDC:  neg OrnDC:  neg Phe deaminase:  neg LeuAA:  + AlkalineP:  + AcidP:  + DNAse:  + Esterase(C4):  neg EstLip(C8):  + Lipase:  d(+) Lipase(C14):  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  neg Indole:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  R(10; disc)
    carbenicil:  S(100; disc)
    penicillin:  R(10U)
    penicillin_G:  Res
    cephalothin:  Res
    gentamicin:  S(10; disc)
    kanamycin:  S(30; disc)
    streptomycin:  S(10; disc)
    nalidixic-acid:  S(30; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  S(30; disc)
    chloramphenicol:  S(30; disc)
    sulfadiazine:  S(250; disc)
    colistin:  S(10; disc)
    polymyxin_B:  Var(MIC50): 50U), MIC90: Var(50U

    References

    SPECIFIC REFERENCES FOR VIBRIO FURNISSII
  • Brayton1986 - Vibrio cincinnatiensis sp. nov., a new human pathogen.
  • Brenner1983 - Vibrio furnissii (formerly aerogenic biogroup of Vibrio fluvialis), a new species isolated from human feces and the environment.
  • Farmer2005gBergey - Bergey's manual of systematic bacteriology. Vol. 2, The Gammaproteobacteria Part B. Family Vibrionaceae, Genus I. Vibrio
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR VIBRIO FURNISSII
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • ...............................
    • Added: April 08, 2021